{
  "ticker": "SLNO",
  "company_name": "Soleno Therapeutics, Inc.",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT04086810",
      "title": "An Open-Label Study of DCCR Tablet in Patients With PWS",
      "status": "WITHDRAWN",
      "phase": "PHASE3",
      "condition": "Prader-Willi Syndrome",
      "start_date": "2019-10",
      "completion_date": "2019-10",
      "enrollment": 0,
      "sponsor": "Soleno Therapeutics, Inc."
    },
    {
      "nct_id": "NCT03714373",
      "title": "Open-Label Extension Study of DCCR in PWS Followed by Double-Blind, Placebo-Controlled, Randomized Withdrawal Period",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Prader-Willi Syndrome",
      "start_date": "2018-10-01",
      "completion_date": "2023-08-17",
      "enrollment": 0,
      "sponsor": "Soleno Therapeutics, Inc."
    },
    {
      "nct_id": "NCT03440814",
      "title": "A Study of Diazoxide Choline in Patients With Prader-Willi Syndrome",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Prader-Willi Syndrome",
      "start_date": "2018-05-09",
      "completion_date": "2020-05-01",
      "enrollment": 0,
      "sponsor": "Soleno Therapeutics, Inc."
    },
    {
      "nct_id": "NCT05701774",
      "title": "Open-Label Extension Study of DCCR in Patients With Prader-Willi Syndrome",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE3",
      "condition": "Prader-Willi Syndrome",
      "start_date": "2023-01-31",
      "completion_date": "2028-06",
      "enrollment": 0,
      "sponsor": "Soleno Therapeutics, Inc."
    },
    {
      "nct_id": "NCT05532020",
      "title": "An Open-Label Study of Diazoxide Choline in Patients With Genetic Obesities",
      "status": "UNKNOWN",
      "phase": "PHASE2",
      "condition": "SH2B1 Deficiency Obesity, Obesity Associated With PCSK1 Mutation (rs6232 Variant), SIM1 Deficiency Obesity",
      "start_date": "2023-01",
      "completion_date": "2024-03",
      "enrollment": 0,
      "sponsor": "Soleno Therapeutics, Inc."
    },
    {
      "nct_id": "NCT04102839",
      "title": "PWS Outcomes Assessment Study",
      "status": "COMPLETED",
      "phase": "",
      "condition": "Prader-Willi Syndrome",
      "start_date": "2019-07-15",
      "completion_date": "2021-06-08",
      "enrollment": 0,
      "sponsor": "Soleno Therapeutics, Inc."
    }
  ],
  "summary": {
    "total_trials": 6,
    "by_phase": {
      "PHASE3": 4,
      "PHASE2": 1,
      "": 1
    },
    "by_status": {
      "WITHDRAWN": 1,
      "COMPLETED": 3,
      "ACTIVE_NOT_RECRUITING": 1,
      "UNKNOWN": 1
    },
    "active_trials": 1,
    "completed_trials": 3,
    "conditions": [
      "Prader-Willi Syndrome",
      "SH2B1 Deficiency Obesity, Obesity Associated With PCSK1 Mutation (rs6232 Variant), SIM1 Deficiency Obesity"
    ],
    "lead_stage": "phase_3"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T13:11:59.418152",
    "search_query": "Soleno Therapeutics, Inc.",
    "url": "https://clinicaltrials.gov/search?term=Soleno+Therapeutics,+Inc."
  }
}